Novartis India jumps 4% on ₹1,250 cr Pfizer trademarks deal

Novartis India jumps 4% on ₹1,250 cr Pfizer trademarks deal. The company acquired Pfizer’s consumer health trademarks in India for ₹1,250 crore, boosting its OTC portfolio. The acquisition strengthens Novartis’s position in the fast-growing wellness segment. It marks a strategic expansion in the domestic pharma space.

📊 STOCKS: NOVARTISIND | 🏢 SECTOR: Pharma | #HIGHIMPACT #Acquisition